These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 23963307

  • 1. A randomized, double-blind, placebo-controlled study of the lowest effective dose of drospirenone with 17β-estradiol for moderate to severe vasomotor symptoms in postmenopausal women.
    Archer DF, Schmelter T, Schaefers M, Gerlinger C, Gude K.
    Menopause; 2014 Mar; 21(3):227-35. PubMed ID: 23963307
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].
    Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):345-9. PubMed ID: 21733370
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptoms.
    Sutter G, Schmelter T, Gude K, Schaefers M, Gerlinger C, Archer DF.
    Menopause; 2014 Mar; 21(3):236-42. PubMed ID: 23963309
    [Abstract] [Full Text] [Related]

  • 4. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
    Lin SQ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Zhou YZ, Wang ML, Zhu J, Chen SR, Su H, Yang CS, Wang SH, Zhang YZ, Dong XJ.
    Climacteric; 2011 Aug; 14(4):472-81. PubMed ID: 21469973
    [Abstract] [Full Text] [Related]

  • 5. Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Obstet Gynecol; 2007 Oct; 110(4):771-9. PubMed ID: 17906008
    [Abstract] [Full Text] [Related]

  • 6. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Oct; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 7. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
    Archer DF, EstroGel Study Group.
    Menopause; 2003 Oct; 10(6):516-21. PubMed ID: 14627859
    [Abstract] [Full Text] [Related]

  • 8. Micro-dose transdermal estradiol for relief of hot flushes in postmenopausal Asian women: a randomized controlled trial.
    Haines C, Yu SL, Hiemeyer F, Schaefers M.
    Climacteric; 2009 Oct; 12(5):419-26. PubMed ID: 19479489
    [Abstract] [Full Text] [Related]

  • 9. 0.5 vs. 1.0 mg estradiol in combination with drospirenone for the treatment of hot flushes.
    Gerlinger C, Gude K, Schmelter T, Schaefers M, Endrikat J.
    Climacteric; 2015 Oct; 18(4):512-7. PubMed ID: 26000627
    [Abstract] [Full Text] [Related]

  • 10. An empirically validated responder definition for the reduction of moderate to severe hot flushes in postmenopausal women.
    Gerlinger C, Gude K, Hiemeyer F, Schmelter T, Schäfers M.
    Menopause; 2012 Jul; 19(7):799-803. PubMed ID: 22228322
    [Abstract] [Full Text] [Related]

  • 11. Transdermal estradiol gel for the treatment of symptomatic postmenopausal women.
    Archer DF, Pickar JH, MacAllister DC, Warren MP.
    Menopause; 2012 Jun; 19(6):622-9. PubMed ID: 22282101
    [Abstract] [Full Text] [Related]

  • 12. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE, Koltun WD, Pascual ML, Day WW, Peterson C.
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [Abstract] [Full Text] [Related]

  • 13. One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
    Genazzani AR, Schmelter T, Schaefers M, Gerlinger C, Gude K.
    Climacteric; 2013 Aug; 16(4):490-8. PubMed ID: 23531117
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: a double-blind, randomized, placebo-controlled, multicenter study.
    Lee BS, Kang BM, Yoon BK, Choi H, Park HM, Kim JG.
    Maturitas; 2007 Aug 20; 57(4):361-9. PubMed ID: 17467203
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women.
    Rozenbaum H, Chevallier O, Moyal M, Durand G, Perineau M, This P, Aerodiol study group.
    Climacteric; 2002 Sep 20; 5(3):249-58. PubMed ID: 12419083
    [Abstract] [Full Text] [Related]

  • 16. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Sep 20; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

  • 17. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB, Lambrecht LJ.
    Menopause; 2009 Sep 20; 16(1):132-40. PubMed ID: 18971794
    [Abstract] [Full Text] [Related]

  • 18. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
    Simon JA, Bouchard C, Waldbaum A, Utian W, Zborowski J, Snabes MC.
    Obstet Gynecol; 2007 Mar 20; 109(3):588-96. PubMed ID: 17329509
    [Abstract] [Full Text] [Related]

  • 19. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA, Schaefers M, Uddin A, Utian WH.
    Menopause; 2009 Mar 20; 16(5):877-82. PubMed ID: 19458560
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
    Speroff L, Haney AF, Gilbert RD, Ellman H, Estradiol Acetate Investigator Group.
    Menopause; 2006 Mar 20; 13(3):442-50. PubMed ID: 16735941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.